An Efficient Tool for Surveying CRF01_AE HIV Type 1 Resistance in Thailand to Combined Stavudine–Lamivudine–Nevirapine Treatment: Mutagenically Separated PCR Targeting M184I/V-Reference-Cited by-同舟云学术

An Efficient Tool for Surveying CRF01_AE HIV Type 1 Resistance in Thailand to Combined Stavudine–Lamivudine–Nevirapine Treatment: Mutagenically Separated PCR Targeting M184I/V

Published:2007-12 Issue:12 Volume:23 Page:1461-1468
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Saeng-Aroon Siriphan¹,Yoshida Lay Myint²³,Ariyoshi Koya²,Taguchi Masataka²,Pathipvanich Panita⁴,Rojanawiwat Archawin¹,Matsuda Masakazu³,Kannagi Mari⁵,Sawanpanyalert Pathom¹,Sugiura Wataru³,Auwanit Wattana¹

Affiliation:

1. National Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.

2. Department of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan.

3. AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.

4. Lampang Hospital, Lampang, Thailand.

5. Department of Immunotherapeutics, Tokyo Medical and Dental University, Tokyo, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2007.0042

Reference19 articles.

1. HIV-1 subtypes and male-to-female transmission in Thailand

2. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand

3. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay, and heteroduplex mobility assay

4. Survival Benefit from Non–Highly Active Antiretroviral Therapy in a Resource-Constrained Setting

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-resistant mutation patterns in CRF01_AE cases that failed d4T+3TC+nevirapine fixed-dosed, combination treatment: Follow-up study from the Lampang cohort;Antiviral Research;2010-07